Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
AIDS Care ; 34(5): 626-632, 2022 05.
Article in English | MEDLINE | ID: mdl-33856950

ABSTRACT

Heterosexuals living with HIV report feeling additional HIV stigma compared to homosexual men, which may affect clinical outcomes. Yet, beyond routinely collected surveillance data, little is known about the characteristics of individuals who acquire HIV heterosexually and clinical outcomes by mode of sexual acquisition have not been directly compared. Using data from the Australian HIV Observational Database, we compared clinical characteristics of those with heterosexually-acquired (Het-HIV) to homosexually-acquired HIV (Hom-HIV) to investigate any differences and their implications for clinical management. 513 Het-HIV and 1467 Hom-HIV patients were included and contributed 3,127 and 9,457 person-years of follow-up, respectively. Compared with Hom-HIV, Het-HIV were more often born outside Australia (62.5% vs 39.9%, p<0.001), less likely to have Hepatitis C (4.8% vs 7.8%, p=0.029) and had lower median CD4 counts at diagnosis (292 vs 450 cells/µL, p<0.001) and cART initiation (270 vs 340 cells/µL, p<0.001). Despite these lower CD4 counts, there were no significant differences between groups for time to the major clinical endpoints of cART initiation, viral suppression, virological failure or all-cause mortality. Het-HIV had a lower risk of loss-to-follow-up than Hom-HIV (aHR 0.78; 95% CI 0.64-0.95). Further studies examining factors associated with, and interventions to inform retention in care are required.


Subject(s)
HIV Infections , Australia/epidemiology , CD4 Lymphocyte Count , HIV Infections/drug therapy , HIV Infections/epidemiology , Heterosexuality , Homosexuality , Humans , Male
2.
J Clin Virol ; 86: 46-51, 2017 01.
Article in English | MEDLINE | ID: mdl-27914286

ABSTRACT

BACKGROUND: The Trinity Biotech Uni-Gold HIV test (Uni-Gold) is often used as a supplementary rapid test in testing algorithms. OBJECTIVE: To evaluate the operational performance of the Uni-Gold as a first-line screening test among gay and bisexual men (GBM) in a setting where 4th generation HIV laboratory assays are routinely used. STUDY DESIGN: We compared the performance of Uni-Gold with conventional HIV serology conducted in parallel among GBM attending 22 testing sites. Sensitivity was calculated separately for acute and established infection, defined using 4th generation screening Ag/Ab immunoassay (EIA) and Western blot results. Previous HIV testing history and results of supplementary 3rd generation HIV Ab EIA, and p24 antigen EIA were used to further characterise cases of acute infection. RESULTS: Of 10,793 specimens tested with Uni-Gold and conventional serology, 94 (0.90%, 95%CI:0.70-1.07) were confirmed as HIV-positive by conventional serology, and 37 (39.4%) were classified as acute infection. Uni-Gold sensitivity was 81.9% overall (77/94, 95%CI:72.6-89.1); 56.8% for acute infection (21/37, 95%CI:39.5-72.9) and 98.2% for established infection (56/57, 95%CI:90.6-100.0). Of 17 false non-reactive Uni-Gold results, 16 were acute infections, and of these seven were p24 antigen reactive but antibody negative. Uni-Gold specificity was 99.9% (10,692/10,699, 95%CI:99.9-100.0), PPV was 91.7% (95%CI:83.6-96.6) and NPV was 99.8% (95%CI:99.7-99.9), respectively. CONCLUSIONS: In this population, Uni-Gold had good specificity and sensitivity was high for established infections when compared to 4th generation laboratory assays, however sensitivity was lower in acute infections. Where rapid tests are used in populations with a high proportion of acute infections, additional testing strategies are needed to detect acute infections.


Subject(s)
HIV Infections/diagnosis , Immunoassay/methods , Mass Screening/methods , Adolescent , Adult , Diagnostic Errors , Female , Humans , Male , Sensitivity and Specificity , Sexual and Gender Minorities , Time Factors , Young Adult
3.
HIV Med ; 16(5): 280-7, 2015 May.
Article in English | MEDLINE | ID: mdl-25604470

ABSTRACT

OBJECTIVES: Rapid HIV testing (RHT) is well established in many countries, but it is new in Australia since a policy change in 2011. We assessed service provider acceptability of RHT before and after its implementation in four Sydney public sexual health clinics. METHODS: Service providers were surveyed immediately after training in RHT and again 6-12 months later. Differences in mean scores between survey rounds were assessed via t-tests, with stratification by profession and the number of tests performed. RESULTS: RHT was rated as highly acceptable among staff at baseline and acceptability scores improved between survey rounds. Belief in being sufficiently skilled and experienced to perform RHT (P = 0.004) and confidence in the delivery of nonreactive results increased (P = 0.007), while the belief that RHT was disruptive declined (P = 0.001). Acceptability was higher for staff who had performed a greater number of tests regarding comfort with their role in RHT (P = 0.004) and belief that patients were satisfied with RHT (P = 0.007). Compared with nurses, doctors had a stronger preference for a faster rapid test (P = 0.027) and were more likely to agree that RHT interfered with consultations (P = 0.014). CONCLUSIONS: Differences in responses between professions may reflect differences in staff roles, the type of patients seen by staff and the model of testing used, all of which may affect the number of tests performed by staff. These findings may inform planning for how best to implement RHT in clinical services.


Subject(s)
Attitude of Health Personnel , Diagnostic Tests, Routine , HIV Seropositivity/diagnosis , Homosexuality , Mass Screening , Patient Acceptance of Health Care/statistics & numerical data , Diagnostic Tests, Routine/statistics & numerical data , Feasibility Studies , Female , Health Care Surveys , Health Facilities , Humans , Male , New South Wales/epidemiology , Patient Education as Topic , Practice Guidelines as Topic , Sexual Behavior , Surveys and Questionnaires
5.
Int J STD AIDS ; 21(5): 337-41, 2010 May.
Article in English | MEDLINE | ID: mdl-20498103

ABSTRACT

We investigated the prevalence of various genital organisms in 268 men with (cases) and 237 men without (controls) urethral symptoms/signs (urethral discharge, dysuria and/or urethral irritation) from two sexual health clinics in Sydney between April 2006 and November 2007. The presence of urethral symptoms/signs was defined as non-gonococcal urethritis (NGU) for this study. Specific aims were to investigate the role of Ureaplasma urealyticum in NGU and the prevalence of Mycoplasma genitalium in our population. Multiplex polymerase chain reaction-based reverse line blot (mPCR/RLB) assay was performed to detect 14 recognized or putative genital pathogens, including Chlamydia trachomatis, M. genitalium, U. urealyticum and U. parvum. U. urealyticum was associated with NGU in men without another urethral pathogen (odds ratio [OR] 2.0, 95% confidence interval [CI] 1.1-3.8; P = 0.04); this association remained after controlling for potential confounding by age and history of unprotected vaginal sex in the last four weeks (OR 2.0, 95% CI: 1.1-3.9; P = 0.03). C. trachomatis (OR 7.5, P < 0.001) and M. genitalium (OR 5.5, P = 0.027) were significantly associated with NGU. The prevalence of M. genitalium was low (4.5% cases, 0.8% controls). U. urealyticum is independently associated with NGU in men without other recognized urethral pathogens. Further research should investigate the role of U. urealyticum subtypes among heterosexual men with NGU.


Subject(s)
Ureaplasma Infections/epidemiology , Urethritis/epidemiology , Adult , Age Factors , Australia/epidemiology , Case-Control Studies , Chlamydia Infections/epidemiology , Chlamydia trachomatis , DNA, Bacterial/genetics , Heterosexuality , Humans , Male , Mycoplasma Infections/epidemiology , Mycoplasma genitalium , Polymerase Chain Reaction , Prevalence , Unsafe Sex , Ureaplasma urealyticum/genetics
6.
Ann Bot ; 103(2): 249-58, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18824473

ABSTRACT

BACKGROUND AND AIMS: Acidification of the cytoplasm is a commonly observed response to oxygen deprivation in plant tissues that are intolerant of anoxia. The response was monitored in plant tissues with altered levels of lactate dehydrogenase (LDH) and pyruvate decarboxylase (PDC) with the aim of assessing the contribution of the targeted enzymes to cytoplasmic pH (pH(cyt)) regulation. METHODS: The pH(cyt) was measured by in vivo (31)P nuclear magnetic resonance (NMR) spectroscopy using methyl phosphonate (MeP) as a pH probe. The potential toxicity of MeP was investigated by analysing its effect on the metabolism of radiolabelled glucose. KEY RESULTS: MeP accumulated to detectable levels in the cytoplasm and vacuole of plant tissues exposed to millimolar concentrations of MeP, and the pH-dependent (31)P NMR signals provided a convenient method for measuring pH(cyt) values in tissues with poorly defined signals from the cytoplasmic inorganic phosphate pool. Pretreatment of potato (Solanum tuberosum) tuber slices with 5 mm MeP for 24 h did not affect the metabolism of [U-(14)C]glucose or the pattern of (14)CO(2) release from specifically labelled [(14)C]-substrates. Time-courses of pH(cyt) measured before, during and after an anoxic episode in potato tuber tissues with reduced activities of LDH, or in tobacco (Nicotiana tabacum) leaves with increased activities of PDC, were indistinguishable from their respective controls. CONCLUSIONS: MeP can be used as a low toxicity (31)P NMR probe for measuring intracellular pH values in plant tissues with altered levels of fermentation enzymes. The measurements on transgenic tobacco leaves suggest that the changes in pH(cyt) during an anoxic episode are not dominated by fermentation processes; while the pH changes in the potato tuber tissue with reduced LDH activity show that the affected isozymes do not influence the anoxic pH response.


Subject(s)
Cytoplasm/metabolism , Fermentation , Molecular Probes/metabolism , Organophosphorus Compounds/metabolism , Plant Cells , Plants/enzymology , Cell Hypoxia , Hydrogen-Ion Concentration , L-Lactate Dehydrogenase/metabolism , Magnetic Resonance Spectroscopy , Oxidation-Reduction , Plant Tubers/enzymology , Plant Tubers/metabolism , Plants, Genetically Modified , Pyruvate Decarboxylase/metabolism , Solanum tuberosum/enzymology , Solanum tuberosum/genetics , Nicotiana/enzymology , Nicotiana/genetics , Zea mays/metabolism
7.
Commun Dis Intell Q Rep ; 25(4): 279-80, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11806666

ABSTRACT

Three cases of meningococcal disease which occurred over a 3 year period in HIV-infected people living in the Wentworth Health Area of Sydney, Australia, are described. None of the 3 had ever received antiretroviral therapy which may, have contributed to development of invasive meningococcal disease.


Subject(s)
HIV Infections/complications , Meningococcal Infections/complications , Adult , Humans , Male , Meningococcal Infections/epidemiology , Meningococcal Infections/microbiology , Middle Aged , Neisseria meningitidis/isolation & purification , New South Wales/epidemiology
8.
J Infect Dis ; 178(3): 858-61, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9728559

ABSTRACT

A phase I study to determine safety, maximum tolerated dose, and biologic response during multiple once-a-week administration of oral imiquimod, an immune response modifier, was conducted in 12 adults with early human immunodeficiency virus (HIV) infection. All completed the dose-escalation phase of weekly dosing at 100-mg increments and received at least one maintenance dose, 100 mg below the patient's toxic dose, for 12 weeks. Dose-limiting toxicity occurred in 3 patients at 200-mg, 5 at 300-mg, and 3 at 400-mg dose levels. One tolerated the 500-mg dose without dose-limiting toxicity. Dose-limiting toxicities included fatigue, fever, malaise, increased transaminases, hypotension, vomiting, and depression. Seven of 12 completed 12 weeks of maintenance. At > or = 200 mg of imiquimod, all patients had biologic responses, measured by elevations in serum interferon, beta2-microglobulin, and neopterin levels. Imiquimod induced pronounced levels of circulating interferon in asymptomatic HIV-infected persons, with variable effect on virus load.


Subject(s)
Aminoquinolines/pharmacology , HIV Infections/drug therapy , HIV , Interferon Inducers/pharmacology , Administration, Oral , Adult , Aminoquinolines/administration & dosage , Aminoquinolines/adverse effects , Female , HIV Infections/blood , HIV Infections/immunology , Humans , Imiquimod , Interferon Inducers/administration & dosage , Interferon Inducers/adverse effects , Interferons/blood , Male , Middle Aged , beta 2-Microglobulin/analysis
9.
AIDS ; 10(5): 521-5, 1996 May.
Article in English | MEDLINE | ID: mdl-8724044

ABSTRACT

OBJECTIVE: To investigate a possible outbreak of tuberculosis in an outpatient HIV treatment facility in Sydney, Australia. DESIGN: Following the diagnosis of pulmonary tuberculosis in an attendee, a prospective screening program was instituted to investigate the potential outbreak. METHODS: Screening of 89 potentially exposed patients included chest radiographs (n = 89), and sputum examination (n = 37) over a period of 23 weeks. RESULTS: No cases of tuberculosis were detected by the screening program. However, three (3.4%) of this cohort developed pulmonary tuberculosis between 8 and 10 weeks following diagnosis of the index case. The incidence of active tuberculosis during the following-up period (median, 7.4 months) was 5.3 per 100 person years and represents the lower limit of possible tuberculous infection, as both latent infection, and undiagnosed tuberculosis among those who died could not be excluded. Mycobacterium tuberculosis strains isolated from the index case and three subsequent cases were found to be identical by DNA typing. CONCLUSION: Nosocomial transmission of tuberculosis in an outpatient treatment setting has been demonstrated. The risk of nosocomial transmission of tuberculosis is significant in institutions caring for HIV-infected patients even in countries with a low prevalence of tuberculosis infection, and highlights the importance of adherence to tuberculosis control guidelines.


Subject(s)
AIDS-Related Opportunistic Infections/epidemiology , Cross Infection/epidemiology , Disease Outbreaks , Outpatient Clinics, Hospital , Tuberculosis, Pulmonary/epidemiology , AIDS-Related Opportunistic Infections/diagnosis , AIDS-Related Opportunistic Infections/transmission , Case-Control Studies , Cross Infection/diagnosis , Cross Infection/transmission , DNA, Bacterial/analysis , Female , Humans , Incidence , Male , Mass Screening , Mycobacterium tuberculosis/isolation & purification , New South Wales/epidemiology , Polymorphism, Restriction Fragment Length , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/transmission
SELECTION OF CITATIONS
SEARCH DETAIL
...